elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28543732-2B7EA03F-CF4F-4887-A993-7CA26B5EF3C5
Q28543732-2B7EA03F-CF4F-4887-A993-7CA26B5EF3C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-2B7EA03F-CF4F-4887-A993-7CA26B5EF3C5
Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection
P50
Q28543732-2B7EA03F-CF4F-4887-A993-7CA26B5EF3C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28543732-2B7EA03F-CF4F-4887-A993-7CA26B5EF3C5
rank
NormalRank
type
BestRank
Statement
P1545
3
http://www.w3.org/2001/XMLSchema#string
P1932
Nagalingeswaran Kumarasamy
http://www.w3.org/2001/XMLSchema#string
P50
Nagalingeswaran Kumarasamy